These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11016878)

  • 1. Proteinase inhibitors and activators strategic targets for therapeutic intervention.
    Deadman J
    J Pept Sci; 2000 Sep; 6(9):421-31. PubMed ID: 11016878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral proteinases--possible targets of antiviral drugs.
    Maliar T; Baláz S; Tandlich R; Sturdík E
    Acta Virol; 2002; 46(3):131-40. PubMed ID: 12580374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the development of gamma-secretase inhibitors.
    Josien H
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):513-25. PubMed ID: 12197309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase proteomics: substrates, targets, and therapy.
    Morrison CJ; Butler GS; Rodríguez D; Overall CM
    Curr Opin Cell Biol; 2009 Oct; 21(5):645-53. PubMed ID: 19616423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of the complex of proteolytic enzymes and their protein inhibitors in embryogenesis of the silkworm].
    Iarygin DV; Klunova SM; Filippovich IB
    Ontogenez; 2001; 32(4):269-76. PubMed ID: 11573423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic enzymes as therapeutic targets - Keystone Symposium. 3-8 February 2002, Keystone, CO, USA.
    Creemers J
    IDrugs; 2002 Mar; 5(3):216-9. PubMed ID: 15562329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
    Pollack SJ; Lewis H
    Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for the most effective screening system to identify cell-active inhibitors of beta-secretase.
    Middendorp O; Lüthi U; Hausch F; Barberis A
    Biol Chem; 2004 Jun; 385(6):481-5. PubMed ID: 15255179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy.
    Fingleton B; Menon R; Carter KJ; Overstreet PD; Hachey DL; Matrisian LM; McIntyre JO
    Clin Cancer Res; 2004 Dec; 10(23):7865-74. PubMed ID: 15585619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-Secretase as a target for drug intervention in Alzheimer's disease.
    Harrison T; Churcher I; Beher D
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.
    Kornacker MG; Lai Z; Witmer M; Ma J; Hendrick J; Lee VG; Riexinger DJ; Mapelli C; Metzler W; Copeland RA
    Biochemistry; 2005 Aug; 44(34):11567-73. PubMed ID: 16114893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General up regulation of Spodoptera frugiperda trypsins and chymotrypsins allows its adaptation to soybean proteinase inhibitor.
    Brioschi D; Nadalini LD; Bengtson MH; Sogayar MC; Moura DS; Silva-Filho MC
    Insect Biochem Mol Biol; 2007 Dec; 37(12):1283-90. PubMed ID: 17967347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and pathogenetic role of proteinase from Acanthamoeba castellanii.
    Na BK; Kim JC; Song CY
    Microb Pathog; 2001 Jan; 30(1):39-48. PubMed ID: 11162184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ATCG of drug discovery.
    Fernandes PB
    Curr Opin Mol Ther; 2000 Dec; 2(6):624-32. PubMed ID: 11249739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental approach to the prophylaxis and treatment of acute lung injury syndrome with proteinase inhibitors and corvitin].
    Moĭbenko OO; Kubyshkin AV; Kharchenko VZ; Horokhova NIu; Semenets' PF
    Fiziol Zh (1994); 2003; 49(4):63-7. PubMed ID: 14509929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
    Doucet A; Overall CM
    Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding.
    Parvathy S; Ehrlich M; Pedrini S; Diaz N; Refolo L; Buxbaum JD; Bogush A; Petanceska S; Gandy S
    J Neurochem; 2004 Aug; 90(4):1005-10. PubMed ID: 15287907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.